TABLE 4.
Changes of PPARγ+cells in liver after antiviral treatment.
| Regression (n = 14) | p-value | Non-regression (n = 9) | p-value | |||
|---|---|---|---|---|---|---|
| Baseline | Post-treatment | Baseline | Post-treatment | |||
| PPARγ+ cells (%) | 61.84 ± 11.15 | 85.17 ± 5.01 | 0.09 | 63.12 ± 7.48 | 80.99 (57.27, 88.45) | 0.091 |
| αSMA+ cells (%) | 21.73 (17.75, 37.18) | 11.53 ± 4.79 | 0.196 | 24.55 ± 4.59 | 26.48 ± 4.85 | 0.704 |
| αSMA+PPARγ+ cells (%) | 14.34 ± 4.6 | 10.57 ± 4.73 | 0.434 | 15.43 ± 3.33 | 20.23 ± 4.08 | 0.283 |
| αSMA+PPARγ+/αSMA+ cells | 0.63 ± 0.11 | 0.87 ± 0.05 | 0.042 | 0.63 ± 0.08 | 0.77 ± 0.06 | 0.079 |